Live Breaking News & Updates on Lemaitre Vascular Company Profile

Stay updated with breaking news from Lemaitre vascular company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Analysts Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target at $73.83

LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year target price among brokerages […] ....

Stifel Nicolaus , Georgew Lemaitre , Davidb Roberts , Conestoga Capital Advisors , Lemaitre Vascular , Congress Asset Management Co , Lemaitre Vascular Inc , Copeland Capital Management , Barrington Research , Vanguard Group Inc , Lemaitre Vascular Company Profile , Securities Exchange Commission , Get Free Report , Maitre Vascular , Director David , Exchange Commission , Capital Advisors , Capital Management , Congress Asset Management , Asset Management , Get Free , Lemaitre Vascular Daily ,

StockNews.com Downgrades LeMaitre Vascular (NASDAQ:LMAT) to Hold

StockNews.com lowered shares of LeMaitre Vascular (NASDAQ:LMAT – Free Report) from a buy rating to a hold rating in a research note released on Saturday. Several other research firms have also issued reports on LMAT. Barrington Research raised their price objective on LeMaitre Vascular from $69.00 to $79.00 and gave the company an outperform rating […] ....

Stifel Nicolaus , Lawrencej Jasinski , Georgew Lemaitre , Lemaitre Vascular , Securities Exchange Commission , Vanguard Group Inc , Lemaitre Vascular Inc , Cynosure Group , Barrington Research , Canada Life Assurance , Lemaitre Vascular Company Profile , Quadrature Capital Ltd , Summit Creek Advisors , Free Report , Moderate Buy , Maitre Vascular , Get Free Report , Exchange Commission , Director Lawrence , Capital Ltd , Creek Advisors , Vanguard Group , Lemaitre Vascular Daily ,